{"id":"W4360962054","doi":"10.3389/fneph.2023.1138416","title":"Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy","year":2023,"lang":"en","type":"article","venue":"Frontiers in Nephrology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Inversago Pharma (Canada)","funders":"Société Francophone du Diabète; Université de Bourgogne; European Regional Development Fund; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Polyuria; Medicine; Endocrinology; Internal medicine; Streptozotocin; Diabetic nephropathy; Albuminuria; Renal function; Polydipsia; Diabetes mellitus; Creatinine; Excretion; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009109128,0.0002832275,0.0004795355,0.0001527367,0.0001064227,0.0001817791,0.0001926791,0.0002217878,0.001420573],"category_scores_gemma":[0.00005916588,0.00006996164,0.0001891494,0.0000769881,0.0001193771,0.0001645299,0.0001149262,0.0006933322,0.0002018785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009754643,"about_ca_system_score_gemma":0.0001849451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003618549,"about_ca_topic_score_gemma":0.0009501111,"domain_scores_codex":[0.9999522,0.00000870302,0.000003024112,0.000009338973,0.000009977911,0.00001679132],"domain_scores_gemma":[0.9999748,0.000002560343,0.000005906102,0.000002100418,0.000004118109,0.00001034326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003748373,0.001028275,0.0002224792,0.0004021803,0.00003026705,0.0001258632,0.00002127002,0.0001683938,0.9668801,0.0001881845,0.0002646762,0.02691988],"study_design_scores_gemma":[0.001798073,0.03016311,0.007821141,0.0001046151,0.0003955422,0.001354013,0.0001103964,0.003396717,0.9396485,0.0002332391,0.01493559,0.00003906673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98276,0.01111271,0.002326372,0.0001883751,0.0001152685,0.00007193488,0.0001707951,0.0001560087,0.003098617],"genre_scores_gemma":[0.9902407,0.005026617,0.001977703,0.0001309108,0.00004835902,0.00004951512,0.0001891286,0.000009614656,0.002327411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001420573,"threshold_uncertainty_score":0.004752338,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01836538073101809,"score_gpt":0.2850810014181556,"score_spread":0.2667156206871375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}